Nebulised lipid–polymer hybrid nanoparticles for the delivery of a therapeutic anti-inflammatory microRNA to bronchial epithelial cells Source: ERJ Open Res, 5 (2) 00161-2018; 10.1183/23120541.00161-2018 Year: 2019
Medical nanoparticles for next generation drug delivery to the lungs Source: Eur Respir J 2014; 44: 765-774 Year: 2014
Interferon-? liposome: a new system to improve drug delivery in the treatment of lung cancer Source: ERJ Open Res, 7 (3) 00555-2020; 10.1183/23120541.00555-2020 Year: 2021
Inhaled liposomal iloprost shows high drug encapsulation, extended release profile and potentials of improving patient compliance Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018
Aerosolization of nanoparticle suspensions in ethanol using Mystic™ drug delivery technology Source: Eur Respir J 2002; 20: Suppl. 38, 541s Year: 2002
Validation of monodisperse corticosteroid aerosols for in-vivo delivery Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement Year: 2008
Pulmonary surfactant as drug delivery system to target lung epithelium: new approach for the treatment of epithelial injury after bleomycin challenge Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018
Improvement of QVAR delivery through a better sorting of drug particles: development of an innovative and easy-to-use spacer Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020
Use of a new feedback tool to optimize inhaled aerosol therapy in patients with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 261s Year: 2006
Assessment of lung deposition and pharmacokinetics in 12 lung transplanted patients after inhalation of a novel liposomal ciclosporin a (CsA) formulation by the eFlow electronic nebuliser Source: Eur Respir J 2007; 30: Suppl. 51, 29s Year: 2007
Extent of inhaled drug deposition in mouth-throat and pulmonary airways: A novel biophysical modelling approach for inhaled therapeutics Source: International Congress 2015 – New models for treating airway diseases Year: 2015
Improvement of pulmonary drug delivery by eFlow™, a novel electronic inhaler making use of a vibrating membrane principle Source: Eur Respir J 2003; 22: Suppl. 45, 472s Year: 2003
Efficacy of imatinib loaded-antiCD44 coated gold nanoparticles: a possible new therapeutic approach to BOS Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes Year: 2019
Polyacrylate nanoparticles: toxicity or new nanomedicine? Source: Eur Respir J 2010; 36: 218-221 Year: 2010
Expanding role of aerosols: systemic drug delivery, gene therapy and vaccination Source: Annual Congress 2007 - ISAM - Expanding role of aerosols: systemic drug delivery, gene therapy and vaccination Year: 2007
Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation Source: Eur Respir J 2011; 38: 1328-1335 Year: 2011
Slow particle dissolution may limit lung absorption of inhaled pharmaceuticals in the lungs Source: Eur Respir J 2006; 28: Suppl. 50, 210s Year: 2006